Cystic Fibrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: Diagnosis of CF, under medical care at Amsterdam UMC-AMC-site. Age: = 18 yrs.; willing/able to give informed consent. Scores on the Generalized Anxiety Disorder Scale (GAD-7) for anxiety and/or Patient Health Questionnaire (PHQ-9) for depression in the mild or moderate range (scores 5-14), without either score above moderate range (>15). Subjects will not be excluded for the following reasons: CF severity or transplant status, if otherwise able to participate. If subjects are medically hospitalized, they may continue to participate. -A history of more severe depression or anxiety currently at mild to moderate levels with or without treatment. This is important to best replicate real-world conditions during depression/anxiety screening in CF Centers to ensure broader generalizability of the intervention. -Participation in concomitant psychosocial treatments (with the exception of formal CBT) or psychopharmacologic treatments at baseline, although these will be tracked and considered in analysis.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: Inability to read, write, and/or follow instructions in Dutch; or no internet access. Severe psychiatric dysfunction, including acute safety risk to self or others. Subjects reporting suicidality on question 9 on the PHQ-9 will be further assessed. Those reporting suicidal intent will be excluded and referred for urgent/emergent care as indicated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will calculate frequency and percentages of feasibility and acceptability scores and summarize the themes of our qualitative data. The differences between baseline and post-intervention will be analyzed. | — |
Contacts
Amsterdam UMC/location VUmc